Accessibility Menu
Mushrooms logo

Mushrooms(OTC) MSRM

Market Cap$609.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-96%
1 Year-25%
1 Month+5%
$0.02
-7.32%
-0.00Today
Mushrooms last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-19
Mushrooms stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.16%USD 0.012026-08-11
1 month+5.17%USD 0.012026-07-20
3 month-0.33%USD 0.022026-05-21
Year to date-37.5%USD 0.022025-12-31
1 year-24.88%USD 0.022025-08-19
3 year-58.78%USD 0.042023-08-18
5 year-96.19%USD 0.402021-08-20
Since inception-99.99%USD 250.002006-11-20

Mushrooms Financials at a Glance

Market Cap

$609.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.24K

Net Income (TTM)

-$166.65K

EPS (TTM)

-$0.00

P/E Ratio

-3.91

Dividend

$0.00

Beta (Volatility)

0.56 (Low)

Price

$0.02

Volume

1,550

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

N/A

MSRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mushrooms

Mushrooms Inc. is a biotechnology company specializing in the development of products derived from mushrooms and mycelium. The company focuses on creating carbon-neutral products, health supplements, and innovative technologies for healthcare and textiles.

Products and Services
  • Health supplements utilizing mushroom extracts
  • Carbon-neutral industrial applications of mycelium
  • Technologies for bacterial detection and nutrient delivery
Growth Outlook
  • Expanding market for sustainable and health-focused products
  • Increased demand for mycelium-based solutions in various industries
  • Potential partnerships with healthcare and textile companies
Financial Highlights
  • Recent quarterly revenue of $0, indicating a focus on R&D
  • Trailing twelve months (TTM) net income of -$133,137
  • Cash and cash equivalents of $40.06 as of March 31, 2026
Mushrooms Inc. has positioned itself in a growing sector that emphasizes sustainability and health. The company's innovative approach to utilizing mycelium for various applications aligns with current market trends favoring eco-friendly solutions. Despite recent financial challenges, including a net income loss, the focus on research and development may pave the way for future growth. The company’s cash position, while limited, reflects ongoing efforts to stabilize operations and explore new opportunities. Investors may find interest in the potential for partnerships and the expanding market for mushroom-based products.
AI Generated • Aug 13, 2026

Industry

Pharmaceuticals

CEO

Kimberly Carlson

Headquarters

Estero, FL 33928, US

MSRM Financials

Key Financial Metrics (TTM)

Gross Margin

-51.46%

Operating Margin

-7606.27%

Net Income Margin

-7438.14%

Return on Equity

272.77%

Return on Capital

N/A

Return on Assets

-1396.17%

Earnings Yield

-25.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$609.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

39.94M

Volume

1.55K

Avg. Volume

8.38K

Financials (TTM)

Gross Profit

-$1.15K

Operating Income

-$170.41K

EBITDA

-$168.25K

Operating Cash Flow

$926.00

Capital Expenditure

-$0.14

Free Cash Flow

$920.00

Cash & ST Invst.

$161.91

Total Debt

$25.00K

Mushrooms Performance Analysis

Mushrooms annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 1,097N/A
20252025-12-31USD 2,384117.3%
Mushrooms sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301885.9%
Q42025-12-31-95.5%
Q12026-03-31-100.0%
Q22026-06-30N/A
Mushrooms annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-41.3%
20232023-12-31USD -0.00-95.9%
20242024-12-31USD -0.0040.0%
20252025-12-31USD -0.00-57.1%
Mushrooms sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31100.0%
Q12026-03-31N/A
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$546.00

-14.7%

Gross Margin

0.00%

N/A

Market Cap

$609.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$101.53K

N/A

Employees

6

N/A

Net Income

-$9.77K

-1168.3%

EBITDA

-$8.99K

-6438.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$161.91

+230.4%

Total Debt

$25.00K

-11.4%

Accounts Receivable

$0.00

N/A

Inventory

$8.16K

-0.8%

Long Term Debt

$25.00K

+0.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-13.96%

N/A

Return on Invested Capital

4.04%

N/A

Free Cash Flow

-$180.00

-105.1%

Operating Cash Flow

-$178.00

-105.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLMNMillennium Prime, Inc.
$0.00+0.00%
AAGRAfrican Agriculture Holdings Inc.
$0.01+0.00%
ASIIAccredited Solutions Inc
$0.00+0.00%
SHMPNaturalShrimp Incorporated
$0.00+1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About MSRM

What is the current price of Mushrooms?

Mushrooms is trading at $0.02 per share.

What is the 52-week range for Mushrooms?

Over the past 52 weeks, Mushrooms has traded between $0.01 and $0.04.

How much debt does Mushrooms have?

As of the most recent reporting period, Mushrooms reported total debt of $25.00K.

How much cash does Mushrooms have on hand?

Mushrooms reported $161.91 in cash and cash equivalents in its most recent financial results.

What is Mushrooms’s dividend yield?

Mushrooms does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.